» Articles » PMID: 39796069

Differential Expression of Proteins Involved in Skin Barrier Maintenance and Vitamin D Metabolism in Atopic Dermatitis: A Cross-Sectional, Exploratory Study

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disorder influenced by proteins involved in skin barrier maintenance and vitamin D metabolism. Using an intra-patient design, this study compared protein expression in intra-lesional (IL) and peri-lesional (PL) skin biopsies from AD patients and examined associations between protein levels, vitamin D status, and clinical features. Forty-four biopsies from twenty-two AD patients were analyzed using antibody microarrays targeting twelve proteins. IL samples had significantly higher total protein levels than PL samples, with a mean difference of 77.7% ( < 0.001). Several proteins, including cathelicidin, cingulin, occludin, filaggrin, and the vitamin D receptor, were upregulated in IL samples. Patients with vitamin D levels below 30 ng/mL showed higher expression of CYP24A ( = 0.054), alpha-catenin ( = 0.043), and haptoglobin ( = 0.033). Increased EASI scores (≥16) were associated with elevated expression of CYP24A ( = 0.024), CYP27B ( = 0.044), filaggrin ( = 0.027), occludin ( = 0.049), and claudin-1 ( = 0.052). Multivariate regression analysis identified significant correlations between protein expression, skin prick test positivity, and low vitamin D levels. These findings suggest that proteins related to epithelial barrier function and vitamin D metabolism are highly upregulated in IL skin regions, offering potential therapeutic targets for improving both skin barrier function and overall disease severity in AD patients.

References
1.
Hanifin J, Baghoomian W, Grinich E, Leshem Y, Jacobson M, Simpson E . The Eczema Area and Severity Index-A Practical Guide. Dermatitis. 2022; 33(3):187-192. PMC: 9154300. DOI: 10.1097/DER.0000000000000895. View

2.
Guttman-Yassky E, Nograles K, Krueger J . Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol. 2011; 127(6):1420-32. DOI: 10.1016/j.jaci.2011.01.054. View

3.
Mitamura Y, Reiger M, Kim J, Xiao Y, Zhakparov D, Tan G . Spatial transcriptomics combined with single-cell RNA-sequencing unravels the complex inflammatory cell network in atopic dermatitis. Allergy. 2023; 78(8):2215-2231. DOI: 10.1111/all.15781. View

4.
Demay M, Pittas A, Bikle D, Diab D, Kiely M, Lazaretti-Castro M . Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024; 109(8):1907-1947. DOI: 10.1210/clinem/dgae290. View

5.
Sakabe J, Kamiya K, Yamaguchi H, Ikeya S, Suzuki T, Aoshima M . Proteome analysis of stratum corneum from atopic dermatitis patients by hybrid quadrupole-orbitrap mass spectrometer. J Allergy Clin Immunol. 2014; 134(4):957-60.e8. DOI: 10.1016/j.jaci.2014.07.054. View